Institutional flow

Institutional Flow — Scan of Sep 5, 2026

Stocks that tracked hedge funds and asset managers added to or newly bought in their latest 13F filings, while retail attention is still low — with the fund-by-fund share changes, estimated entry prices and an AI read on why they may be buying.

Next scan: tomorrow by 9:00 AM ET. A new scan is posted every Saturday by 9:00 AM ET.
5stocks qualified
4funds adding
3new positions
$4.36Bheld by those funds

AIThis scan

We compared the 13F-HR filings for periods ending 2026-06-30 (filed Aug 14, 2026) against 2026-03-31 (filed May 15, 2026) for the five funds on the watchlist: Berkshire Hathaway, Bridgewater Associates, Renaissance Technologies, Citadel Advisors, and Two Sigma Investments. Roughly forty manager-tickers cleared the per-fund acceleration thresholds; only five names were accumulated by two or more funds simultaneously without failing the retail-attention screen. The single most striking finding: Medtronic (MDT) was a fresh Renaissance opening, a Two Sigma quintupling (+417%), and a Citadel add (+153%) in the same quarter — three unrelated shops piling into a boring med-device name one quarter before Medtronic's Sept 1 beat-and-raise (Q1 FY27 organic growth +13.7%, guidance lifted). Institutions front-ran that print by a full quarter. Berkshire's mega-cap GOOGL/GOOG add and Delta rebuild both cleared the acceleration filter but did not survive the multi-fund + retail-attention screens (mega-cap ex-carve-out).

How this scan was run

Acceleration filter: for each CUSIP appearing in either quarter, require ≥ 2 supporting funds and either a new position or ≥ 25% Q/Q share growth in aggregate. Puts (putCall="PUT") excluded — long calls counted. Per-fund dollar thresholds tuned by manager style: Berkshire and Bridgewater at $25M+ position size, quant managers (RenTech, Two Sigma, Citadel) at $100–200M to filter intra-quarter noise given their higher turnover — a caveat, not a rejection of their signal. All five configured funds returned holdings via fetch_13f_holdings — no failures. Retail-attention filter required ≥ 2 of {30-day Google Trends ≤ 25 for ticker AND name, mainstream news count ≤ 15/mo, not on r/wallstreetbets or Stocktwits trending top-100, options call/put OI ratio < 2.0}; those metrics below are 2026-09-05 directional estimates from public news volume and Stocktwits mention data, not precise counts. CUSIP→ticker resolved via SEC company-tickers JSON and issuer-name lookup; no ambiguous dual-class picks in the final five. Avg entry price is quarter-end value ÷ shares aggregated across supporting funds — 13F does not disclose actual cost basis, so treat as an estimate anchored to 2026-06-30 mark.

#1

MDT

Medtronic plc
Health CareMkt cap $120.5BNext earnings Nov 18, 2026
Price
$94.17
Est. fund entry
$78.23+20.4%
Shares held
12.6M
Position value
$986.7M
Funds that added
FundPrior sharesShares nowChange
Renaissance Technologies—3.17MNew position
Two Sigma Investments626.9K3.24M+417.0%
Citadel Advisors2.45M6.20M+153.1%
Retail attention 3 of 4 signals quiet
Google Trends15/100quiet
News, 30 days25 articlesbusy
Call/put OI1.20quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Three unrelated managers piled into Medtronic in the same quarter — Renaissance opened a fresh 3.2M-share stake, Two Sigma quintupled its position (+417%), and Citadel added 153% — all before MDT delivered a beat-and-raise on Sept 1 (Q1 FY27 organic growth +13.7%, cardiovascular +19.5%, guidance lifted). Retail still frames MDT as a slow-growing diabetes-and-dividend name; the institutional read is a re-rating driven by pulsed-field ablation (Affera/Sphere-9) inflecting the CRM franchise, Hugo robotic surgery ramping, and diabetes accelerating simultaneously. Multi-manager, pre-catalyst positioning into a name Wall Street stopped covering with conviction.

What would prove it wrong

Position is now 20% above the funds' Q2 mark — the near-term surprise is priced. A stronger USD or Chinese CRM pricing pressure compresses the FY27 EPS bridge; Boston Scientific's Farapulse continues to fight for PFA share; next print is not until mid-November so the fresh catalyst is behind us.

#2

TXN

Texas Instruments Incorporated
Information TechnologyMkt cap $235.0BNext earnings Oct 21, 2026
Price
$258.44
Est. fund entry
$298.07-13.3%
Shares held
6.23M
Position value
$1.86B
Funds that added
FundPrior sharesShares nowChange
Renaissance Technologies851.3K1.40M+64.7%
Two Sigma Investments180.8K1.38M+663.5%
Citadel Advisors1.64M3.45M+110.1%
Retail attention 3 of 4 signals quiet
Google Trends18/100quiet
News, 30 days20 articlesbusy
Call/put OI1.40quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Three funds tripled or opened outsized TXN positions in Q2 while the stock underperformed. The tell is Two Sigma going from a placeholder 181k shares to 1.38M (+663%) alongside Citadel more than doubling to 3.45M shares — quants rarely converge on an out-of-favor analog name. Analog-semi bookings troughed in Q1; automotive plus industrial (~66% of TXN revenue) are lapping the 2024-25 destocking cycle. The Oct 21 Q3 print is the catalyst institutions positioned for — a book-to-bill inflection retail is still ignoring while the tape hates capex-heavy analog stories.

What would prove it wrong

Already 13% underwater from quarter-end entry. If auto/industrial destocking extends another quarter, the Oct 21 report could reset EPS lower before the cycle turns. Aggressive Sherman/Lehi capex still pressures FCF conversion; margin recovery is a 2027 story if bookings disappoint.

#3

CME

CME Group Inc.
FinancialsMkt cap $101.0BNext earnings Oct 21, 2026
Price
$281.29
Est. fund entry
$220.83+27.4%
Shares held
3.10M
Position value
$684.6M
Funds that added
FundPrior sharesShares nowChange
Renaissance Technologies34.8K680.0K+1854.2%
Two Sigma Investments1.15M2.42M+110.0%
Retail attention 4 of 4 signals quiet
Google Trends8/100quiet
News, 30 days12 articlesquiet
Call/put OI1.00quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Renaissance effectively opened a new $150M CME position (up from a token 35k shares) while Two Sigma doubled its stake in the same quarter — both quants sizing up an exchange feeding on structurally elevated rate volatility. CME's rate-complex ADV printed record highs into Q2 as global macro repricing (Fed, JGB, ECB) drove hedging flows. This is a monopoly-toll business retail rarely discusses. The Oct 21 print is the catalyst — if rate-vol is structural rather than cyclical, the multi-year earnings power is materially higher than sell-side base cases.

What would prove it wrong

Already up ~27% from the funds' Q2 mark, so the cheapest window closed. A Fed pivot to firmly on-hold posture collapses the front-end vol lever the whole thesis rests on. Longer-tail: emerging DEX and prediction-market competition for select contracts is real but not near-term.

#4

PCG

PG&E Corporation
UtilitiesMkt cap $32.0BNext earnings Oct 22, 2026
Price
$14.30
Est. fund entry
$16.82-15.0%
Shares held
25.4M
Position value
$428.0M
Funds that added
FundPrior sharesShares nowChange
Bridgewater Associates24.5K5.93M+24078.9%
Two Sigma Investments7.06M19.5M+176.5%
Retail attention 3 of 4 signals quiet
Google Trends22/100quiet
News, 30 days35 articlesbusy
Call/put OI1.30quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Bridgewater effectively opened a fresh 6M-share PG&E position from a rounding-error base (+24,000%) while Two Sigma tripled its stake — dual accumulation into California's fastest-growing regulated rate base right as the AI data-center power queue is being formally disclosed. The late-August wildfire-legislation selloff drove PCG from $17 to $14, but AB-1054 wildfire-fund protections remain in place and the recent fires have not been attributed to PCG equipment. Funds sized up before Oct 22 Q3 — and the recent drawdown now hands new buyers a lower entry than the funds got.

What would prove it wrong

Wildfire liability tail is real — any 2026-27 fire attribution to PG&E equipment reopens the balance-sheet debate. California IOU regulatory support could weaken if follow-on legislation carves out AB-1054 protections. News count is elevated (~35/mo) because of wildfire coverage, not retail speculation, but the noise raises the entry risk.

#5

ICE

Intercontinental Exchange, Inc.
FinancialsMkt cap $92.0BNext earnings Oct 29, 2026
Price
$161.26
Est. fund entry
$123.11+31.0%
Shares held
3.30M
Position value
$406.1M
Funds that added
FundPrior sharesShares nowChange
Renaissance Technologies—1.27MNew position
Two Sigma Investments—2.03MNew position
Retail attention 4 of 4 signals quiet
Google Trends8/100quiet
News, 30 days10 articlesquiet
Call/put OI1.10quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

The cleanest new-position signal of the scan: both Renaissance ($156M) and Two Sigma ($250M) opened ICE from zero in the same quarter. ICE monetizes three flywheels retail rarely models together — energy derivatives (record complexity in gas markets), mortgage tech (Black Knight synergy still ramping), and fixed-income data. Two quants independently concluded ICE's earnings power has stepped up. The stock is up ~30% from their Q2 entry mark, so the tape is beginning to figure it out — but ICE remains under-owned relative to CME or MSCI on any comparable-multiples basis.

What would prove it wrong

Mortgage-tech synergies remain uneven quarter to quarter — a soft refi/origination backdrop through year-end delays the Black Knight ROIC story. Any regulatory push on exchange fees or a reversal in energy vol tightens the growth flywheel. Foreign benchmark competition (TTF, EU ETS) is a slow-burn overhang.

All scans

Based on public SEC 13F filings. Funds file them up to 45 days after each quarter ends, so they show positions at quarter-end, not today. Average entry prices are estimates (filing value ÷ shares) — 13F filings don't report cost basis. The summaries, theses and risks are written by AI as a research aid — they are not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Institutional Flow tracks the quarterly 13F filings of a watchlist of hedge funds and asset managers and flags the stocks several of them are accelerating into — new positions or sharply larger ones — while search interest, news coverage and options positioning say the retail crowd hasn't noticed yet. It is free, and a new scan is posted every Saturday by 9:00 AM ET. How to read Institutional Flow →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartCreate a free account

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.